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Summary 
The  mucosa  of the  gastrointestinal  tract  is  presumably  an  important  reservoir  for  human 
immunodeficiency virus type 1 (HIV-1), but the level of virus-expressing cells within the mucosa 
of infected patients is not known.  To study this issue, we identified HIV-1 mRNA-expressing 
(positive) mononuclear cells by in situ hybridization  in specimens of esophageal mucosa from 
eight patients  with  acquired immune deficiency syndrome (AIDS) and esophageal infections. 
Such cells were not found in four patients with AIDS and no esophageal disease.  Immunocyto- 
chemical staining revealed that  the mononudear cells expressing HIV-1 mRNA were lamina 
propria macrophages. The prevalence of positive cells was measured by triplicate determinations 
in each of three experiments using an inverse  sampling technique.  No significant differences in 
prevalence were found among patients or among experiments. The overall prevalence of HIV-1 
mRNA-expressing cells in the esophageal lamina propria was 0.059  •  0.01%. This prevalence 
of cells expressing HIV-1 mKNA in the mucosa of  patients with mucosal infections may reflect 
the local abundance of stimuli such as bacterial endotoxin and certain cytokines capable of inducing 
viral  transcription. 
T 
he mucosa of the gastrointestinal  tract plays a critical 
role in the immunopathogenesis of HIV-1 infection (1, 
2). Among homosexual men, still the largest population of 
persons at risk for HIV-1 infection in developed countries, 
the mucosa offers access to host tissues for both virus-infected 
cells  and cell-free virus.  As the largest lymphoid organ  in 
the body, the mucosal lamina propria may also serve as a poten- 
tial reservoir for HIV-l-infected mononuclear cells. Such cells 
likely contribute, either directly or indirectly, to the reduc- 
tion  in  lamina  propria  helper/inducer  (CD4 +)  cells  (3), 
which parallels  the reduction in circulating  CD4 + T  cells. 
As local immunosuppression progresses, the esophagus and 
intestinal  tract become sites of opportunistic infection(s)  (4, 5). 
Despite involvement of the mucosa in the immunopatho- 
genesis of AIDS, information  on the presence of HIV-1 in 
the gastrointestinal tract mucosa is limited. For example, the 
level of HIV-1 mRNA-expressing  cells  in the mucosa has 
not been determined, yet such cells likely have an important 
impact  on mucosal immune  function.  Therefore,  we used 
in situ hybridization and immunolabeling to identify HIV-1 
KNA-expressing macrophages in the mucosa and then de- 
termined the prevalence of these cells in patients with AIDS. 
Materials and Methods 
MucosalSpecimens.  Esophageal  biopsy specimens were obtained 
from eight patients with AIDS who were part of an ongoing study 
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of gastrointestinal  opportunistic  infection(s) in AIDS (4, 5). The 
histologic diagnoses for the eight  patients  were esophagitis due 
to Candida albicans  in six patients, cytomegalovirus in one patient, 
and C. albicans  plus herpes simplex virus in one patient. Esophageal 
mucosa from four patients with AIDS but no esophageal disease 
served as control tissue. 
In Situ Hybridization.  Biopsy specimens were evaluated for HIV-1 
RNA by in situ hybridization according to our previously described 
protocol  (6,  7). Briefly, esophageal biopsy specimens were fixed 
in 1.3 M formaldehyde (8), embedded in paraffin, sectioned, and 
then bonded to silanized microscope slides (3% triethoxy-3-amino- 
propyl silane in anhydrous acetone followed by washing in distilled 
water), deparafl~nized, and hydrated in graded alcohols. Slides were 
treated with 0.2 M HC1 (30 min) and digested with proteinase 
K (0.1 mg/ml; Sigma Chemical Co., St. Louis, MO) for 15 min. 
The slides were derivatized, first with acetic anhydride followed 
by succinic anhydride (0.1 M) in triethanolamine  buffer (0.1 M, 
pH 8.0) to remove background and to block myelocytic basic pro- 
tein. After prehydridization, the slides were hybridized overnight 
in probe mixture (200,000 counts per slide) with an excess of non- 
sense mRNA (Escherichia coli) foLlowed  by extensive washing and 
removal of single-stranded KNA with ribonudease  A and T1 fol- 
lowed by washing.  The slides were dipped in Kodak NTB 2 or 
3 emulsion (Eastman Kodak Co., Rochester, NY) and exposed for 
4 d. Slides were developed in Kodak D19 (1:1, 15~  4 min) and 
stained with hematoxylin  and eosin. 
The RNA probes used to detect HIV-1 mRNA were synthe- 
sized using x2sI- or 35S-labeled  nucleotide triphosphates from DNA 
templates of subclones of HIV-1 (strain LAI). Five subclones en- 
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minal repeat-gag, BgllI, 2.01 kb; (b) gag-~l, HindlII-KpnI, 2.6 
kb; (c) pol, BgllII-EcoRI, 2.65 kb; (d) VIF, VPIL, Tat, Rev, VPU, 
KpnI-KpnI, 2.4 kb; and (e) env, SalI-BgllII, 2.65 kb. Probes were 
synthesized in the antisense and sense configuration, each subclone 
having two promoters, and then sheared by alkaline hydrolysis to 
yield 200 base RNA fragments. Probe fragments were combined 
in equal amounts to make a single antisense and a single sense probe 
with the sensitivities  of "~30-300 copies of target RNA per cell. 
The sensitivity was determined by experiments in which a known 
number of cell-free viral particles fixed in a fibrin clot and hybrid- 
ized with the above pooled probes was shown to yield 2.4-3.0 silver 
grains  per viral genome (Fox, C.H., unpublished observations). 
Four serial sections from each tissue specimen were probed for HIV-1 
RNA with the antisense  probe. 
The evaluation of each tissue specimen included the following 
controls: (a) sections of known HIV-l-infected and uninfected brain 
tissue from another patient; (b) HIV-l-infected and uninfected H9 
ceils; (c) a "nonsense" control probe; and (d) two serial tissue sec- 
tions from each specimen run with the sense probe. Slides were 
examined by dark-field and bright-field microscopy. Ceils (excluding 
eosinophfls and cells at the section edge) were considered positive 
when more than 20 white grains (dark-fild) or black grains (bright- 
field) were detected overlying a cell in an area of 200 ~tm  z in a typ- 
ical stellate pattern. This procedure was replicated three times in 
each of three experiments (nine separate determinations for each 
of eight patients). In the fist experiment, bright-field illumina- 
tion was used to identify positive cells, and the procedure was un- 
blinded, whereas the second and third experiments were blinded, 
dark-field illumination was used, and the number of positive cells 
in the first field with at least  one positive cell was counted. 
Immunohistochemical Staining.  Immunohistochemical staining 
was performed to identify cells  that expressed  HIV-1  mRNA. 
Briefly, formaldehyde-fixed sections of mucosal tissue were stained 
for I h with the following monoclonal antibodies:  OPD4 (Dako, 
Carpinteria, CA), which reacts with helper/inducer T  lympho- 
cytes; HAM56 (Dako), which labds fixed tissue macrophages; or 
CD21 (Dako), which reacts with mature B cells and follicular den- 
dritic cells. After washing, the slides were treated sequentially for 
30 rain with biotinyhted rabbit anti-mlgG and alkaline phosphatase- 
labeled streptavidin (Dako) and then reacted for 10 rain with new 
fuchsin chromogen substrate (Dako). For double-labeling experi- 
ments, slides were first stained by the immunohistochemical pro- 
cedure and then hybridized with RNA probes to detect HIV-1 
mRNA according to the in situ hybridization procedure described 
above (9,  10). 
Statistical Analysis.  In each slide, nonoverlapping microscopic 
fields were examined until a field containing one or more positive 
ceils was found (11). The number of negative fields observed (N) 
and the number of positive cells in the last  field (M) were used 
in the formuh N  +  1/(M +  1), which is an estimate of the number 
of fields per positive cell. (1/(M  +  1) is the expected fraction of 
the last field counted ff cells were examined one by one.) The 
reciprocal,  1/[N  +.  1/(M  +  1)], is an estimate of the number of 
positive cells per field, which, when divided by the average number 
of ceils per fidd,  yields  the prevalence  (P§  of HIV-1  mRNA- 
expressing cells in  the esophageal mucosa:  P+  =  1/I4Q[N  + 
1/(M  +  1)]] where Q is the average number of cells per quadrant. 
If positive ceils are assumed to be distributed in the lamina propria 
according to a spatial Poisson law with a mean of O ceils per field, 
then N  will have a geometric distribution (12) exp(-N0)[1  - 
exp(- 0)], N  =  0,1,2 .... and M, a decapitated Poisson distribution 
(13), exp(-0)0M/lM![1  -  exp(-0)l], M  =  1,2 ....  In Tables 1 
and 2 are shown the observed numbers of negative fields per ex- 
perimental replicate (Table 1) and the observed numbers of positive 
cells per positive field (Table 2). Comparison of observed values 
with the corresponding expected values based on the assumed dis- 
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Table  1.  Distribution of Microscopic Fields Lacking HIV-1 
mRNA Positive Cells from Eight Patients with AIDS 
Number of negative fields per replicate 
5  or 
0  1  2  3  4  more  Total 
Observed  15  26  20  8  3  0  72 
Expected  29.6  17.4  10.3  6.1  3.6  5.1  72.0 
(geometric)* 
Expected  17.5  24.7  17.5  8.3  2.9  1.1  72.0 
(Poisson)* 
* For definition of geometric and Poisson (waiting time) distributions 
see Statistical Analysis. Goodness-of-fit  chi-square: geometric, 26.5, 3 df, 
p <0.001; Poisson, 1.04, 3 (if, p <0.50. 
Table  2.  Distribution of Positive Cells in Hybridized Esophageal 
Biopsy Specimans from Eight Patients with AIDS 
Number of positive cells per positive field 
I  2  3  4  5 or more  Total 
Observed  23  12  11  2  0  48 
Expected  22.5  15.3  7.0  2.4  0.8  48.0 
Poisson* 
" For definition of (decapitated) Poisson distribution see Statistical Anal- 
ysis. Goodness-of-fit chi-square =  3.46, 2 df, p  =  0.17. 
tributions shows  poor agreement in the data presented in Table 
1 (Expected [geometric], X  2 =  26.5, 3 dr, p  <0.001) but fairly 
good agreement in those in Table 2 (Expected [Poisson],  X  2 = 
3.46, 2 dr, p  =  0.17).  The observed values in Table 1, however, 
are quite well fitted by a Poisson waiting time distribution (X  2 = 
1.04,  3 dr, p  >0.50). 
A square root transformation (14) was applied to the observed 
values of N  +  1/(M  +  1) and a three-way analysis of variance 
carried out (factors: patient, experiment, replicate order within ex- 
periment). Normality of the residuals was checked with a Shapiro- 
Wilk test (15). No significant  main effects were found; however, 
there was a highly significant patient-experiment interaction due 
primarily to data collected in the second experiment. 
Results 
Detection  of HIV-l-infected  Cells  in  Esophageal  Mucosa. 
Cells  expressing HIV-1  rnRNA were identified by in situ 
hybridization in biopsy specimens of esophageal mucosa from 
each of eight patients with AIDS and an opportunistic esoph- 
ageal infection. HIV-1 mRNA-expressing ceils occurred as 
single cells or in groups of up to four positive ceils per field 
(Fig.  1 A).  Positive ceils were detected only in the lamina 
propria (Fig.  1 B) and appeared to be mononuclear leuko- 
cytes based on size, morphology, and nuclear configuration. 
In contrast, HIV-1 mRNA-expressing cells were not detected 
in the control mucosa from AIDS patients without esophageal 
disease. Figure  1.  Mucosal  biopsy of the esophagus from two AIDSpatients probed by in situ hybridization for HIV-1 mRNA. (A) Bright-field illumination 
shows two HIV-1 mRNA-expressing cells (arrows) within the lamina propria (hemat~o~ylin and eosin, 63x). (B) Dark-field illumination shows several 
HIV-1 mRNA-expressing cells detected by the collections of white dots which represent silver grains in the developed image (400x). 
Immunohistochemical  Identification of  HIV.1 mRNA--expressing 
Cells.  Mucosal biopsy specimens from four patients were 
evaluated for  the  presence  of OPD4 + T  cells, HAM56 + 
macrophages,  and CD21 + B or follicular dendritic cells by 
immunohistochemical staining and for the presence of HIV- 
1 mRNA-expressing cells by in situ hybridization. Lamina 
propria macrophages (Fig. 2), but not lymphocytes (data not 
shown), expressed  HIV-1 mRNA by this double-labeling tech- 
nique.  The productively infected cells were present in the 
lamina propria, but not in the epithelium. These findings 
corroborated  the morphological findings, which showed that 
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the cells expressing HIV-1 mRNA were mononuclear cells 
located exclusively within the lamina propria. 
Prevalence of Mucosal Mononuclear Cells Expressing HIV-1 
mRNA.  Tables  1 and 2 summarize the data from the three 
experiments. The number of cells inspected per replicate was 
,~2,000  (on average 4  x  349  x  1.416 --  1976.74), which 
together with the very small number of positive cells detected, 
suggested that the number of negative fields  read before finding 
a positive field would follow a Poisson distribution (12). Our 
data (Table 1, Expected, Poisson distribution) confirmed this 
supposition: goodness-of-fit chi-square =  1.04, 3 dr, p )0.50. 
Smith et al.  Brief Definitive Report Figure  2.  Protease-digested section of esophageal mucosa from an AIDS patient hybridized with HIV-1 3sS-labeled  RNA antisense probe and stained 
with HAM56. Localization of HIV-1 mRNA signal over a HAM56 + mononuclear cell in the lamina propria indicates that a lamina propria macro- 
phage is productively infected with HIV-1. 
Table  3.  Prevalence of Cells Expressing  1"11I/'-1 RNA  in Esophageal Mucosa among  Eight Patients with AIDS 
Patient 
Average no.  ceils/ 
quadrant  (Q) 
Average no,  negative 
fields counted  (N)  Prevalence  ( x 104) *  (P+) 
1  167  1.333  8.88 
2  171  1.222  9.28 
3  293  1,556  4.47 
4  336  1.333  4.41 
5  326  .667  7.52 
6  180  1.444  7.72 
7  650  2.222  1.49 
8  429  1.555  3.05 
Mean  •  SEM  349  •  5  1.416  •  .152  5.86  •  1.02 
"  P+  -  1/[4Q[N  +  1/(M  +  1)]  1 where Q  is the average  number  of cells_,per quadrant  and N,  the average  number of negative fields counted 
per patient; M is the overall average number of positive cells per positive field (M i  88/48  =  1.833).  See Statistical Analysis for derivation of formuh. 
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to form small aggregates since, compared with the corre- 
sponding numbers of fields expected with a random distri- 
bution of cells (see Table 1, Expected, geometric distribu- 
tion), there was a defidt of fidds free of such cells (15 vs. 
29.6) but an excess of fields with two to four positive cells 
(31 vs.  19.9). 
Table 3 shows the average number of calls enumerated per 
quadrant (i~) for each patient and the corresponding average 
number of fields counted until a field having at least one posi- 
tive  cell  was  found  (1~). Individual  patient  prevalences 
were calculated by introducing the estimates i~ and/q' into 
the formula at the foot of Table 3.  The overall prevalence 
of mononuclear cells expressing HIV-1 mRNA in esophageal 
mucosa of patients with AIDS was estimated by taking the 
arithmetric mean of the individual patient prevalences: mean 
P+  =  5.86  x  10 -4. The corresponding standard error was 
1.02  x  10 -4.  A  95%  confidence interval for mean P+  is 
(3.45  -  8.26)  x  10 -4. 
Discussion 
Using in situ hybridization, we identified mononuclear cells 
expressing HIV-1 mRNA in the lamina propria of esophageal 
mucosa from eight AIDS patients with esophageal oppor- 
tunistic infections. Double-labeling experiments showed that 
the productively infected cells were macrophages. The deple- 
tion of mucosal CD4 + lymphocytes, which parallels  the 
depletion of circulating CD4 + lymphocytes in patients with 
AIDS (3),  may have contributed to our inability to detect 
HIV-1  mRNA  expressing T  lymphocytes in  the lamina 
propria. Quantitative analysis of the hybridized slides revealed 
that on the average, one HIV-l-infected cell per "~2,000 
lamina propria mononuclear cells (0.059%) actively expressed 
viral RNA at levels detectable by in situ hybridization. We 
recognize, however, that this percentage may actually underes- 
timate the prevalence of mucosal cells infected with HIV-1, 
since our technique detected cells expressing viral RNA and 
not cells containing only integrated or extrachromosomal 
proviral DNA, which ranges between 0.1% and 13.6% of 
mononudear cells in blood (16, 17). 
Although HIV-1 has been identified in an esophageal ulcer 
(18) and in intestinal mucosa (4, 6, 7, 19-23), this is the first 
quantitative assay of the viral burden in mucosal tissue from 
patients with AIDS. Moreover,  we believe that our evalua- 
tion is to date the most reliable estimate of the prevalence 
of cells expressing HIV-1 transcripts in a body tissue or fluid. 
The number of negative fields counted during inverse sam- 
pling of the hybridized tissue sections was shown to follow 
a Poisson distribution, and an analysis of variance showed 
no significant differences in counts of negative fields among 
the eight patients or three experiments. This method of es- 
timating the prevalence  of mRNA positive cells obviates 
counting the total number of cells in each field. Instead, the 
average total number is estimated independently, thereby saving 
appreciable  time and effort. 
The 0.059% prewalence  of HIV-1 mRNA-expressing cells 
in esophageal mucosa reported here is 6-60 times higher than 
the apparent frequency (0.001-0.01%) of cells expressing viral 
RNA in lymph nodes from patients with AIDS (24). In the 
latter study, however, Harper et al. (24) used a different hy- 
bridization  protocol and  did not  quantitate viral  burden 
(number of infected cells) by the inverse sampling technique 
described above. Ideally, the same in situ hybridization pro- 
tocol, probes, and quantitative analysis should be used to com- 
pare frequencies of HW-1 mRNA-expressing cells in different 
organs. 
Recently, we used protease-digested tissue in hybridiza- 
tion experiments to show that lymph nodes are important 
reservoirs of free virus during early HIV-1 infection and that 
this reservoir disappears as the germinal centers involute with 
advancing disease (9). More recently,  Embretson et al. (25) 
extended these observations by combining in situ hybridiza- 
tion and polymerase chain reaction to show that high numbers 
of CD4 + cells in the germinal centers and follicular mantle 
of lymph nodes from patients with early HIV-1 infection 
were latently infected with HIV-1 DNA. In contrast to these 
studies, we determined the frequency of productivdy infected 
(HIV-1 mRNA-expressing) cells among all mucosal cells and 
performed these studies on tissues from patients with late 
HIV-1 infection (AIDS and opportunistic infections). Thus, 
during late HIV-1 disease the expression of HIV-1 by mono- 
nudear cells in gastrointestinal mucosa may be different from 
that of lymph nodes where productively infected cells are no 
longer present (9,  10, 25). 
The frequency of mucosal cells productively infected with 
HIV-1 reported here may reflect the local availability of ex- 
tracellular stimuli capable of activating the cellular transcrip- 
tion factors that regulate viral replication. Stimuli that may 
be present in the gastrointestinal  tract mucosa that are capable 
of activating lymphocytes and macrophages for HIV-1 ex- 
pression include bacterial lipopolysaccharide (26, 27), although 
this is still controversial  (28, 29), and tumor necrosis factor 
ot (30, 31), which is abundantly expressed by mucosal mac- 
rophages in some patients (7). Elucidating the local events 
that promote HIV-1 expression by mononuclear cells in the 
mucosa will be critical to understanding the role of the gas- 
trointestinal tract as a reservoir  for HIV-1. 
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